MXCT MaxCyte, Inc.
$1.13
MaxCyte, Inc. (MXCT) Earnings News
Earnings press releases, previews and reviews for MaxCyte, Inc. (MXCT), newest first. Our most recent is review: MaxCyte Beats Big and Raises Again, but the Akron Bio Deal Changes the Story.
Tuesday
November 10, 2026
5:45 PM ET
MaxCyte Beats Big and Raises Again, but the Akron Bio Deal Changes the Story
Earnings Whispers · Review
Tuesday
November 10, 2026
6:01 AM ET
MaxCyte Reports Third Quarter 2026 Financial Results and Updates Full Year 2026 Total Revenue Guidance
Tuesday
November 3, 2026
11:26 AM ET
MaxCyte's Raised Outlook Leaves Wall Street Lagging Ahead of Third-Quarter Report
Earnings Whispers · Preview
Wednesday
October 14, 2026
8:05 AM ET
MaxCyte Reports Preliminary Third Quarter 2026 Revenue and Raises Full Year 2026 Revenue Guidance
Wednesday
August 12, 2026
4:05 PM ET
MaxCyte Reports Second Quarter 2026 Financial Results
Wednesday
July 15, 2026
4:05 PM ET
MaxCyte to Report Second Quarter 2026 Financial Results on August 12, 2026